Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

Circulation. 2015 Oct 27;132(17):e213-4. doi: 10.1161/CIRCULATIONAHA.115.017260.

¹ Cardiothoracic Pharmacology, Vascular Biology, National Heart and Lung Institute, Imperial College, London, UK.
² The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK.
³ Cardiothoracic Pharmacology, Vascular Biology, National Heart and Lung Institute, Imperial College, London, UK, King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia.
⁴ MRC Clinical Sciences, Imperial College London, Nitric Oxide Signalling Group, Hammersmith Hospital, London, UK.
⁵ School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.
⁶ Institute of Clinical Pharmacology, Johann Wolfgang Goethe-University, Frankfurt, Germany.

No abstract available

Publication types